37481-41-7 Usage
Uses
Used in Pharmaceutical Industry:
2,6-Dimethyl-N-(1,2,3,4-tetrahydro-2-methylisoquinolin-5-yl)benzamide is used as a therapeutic agent for neurodegenerative disorders such as Alzheimer's disease and schizophrenia. Its application is based on its ability to modulate serotonin neurotransmission in the brain, potentially improving cognitive function and alleviating symptoms associated with these conditions.
Used in Research and Drug Development:
2,6-Dimethyl-N-(1,2,3,4-tetrahydro-2-methylisoquinolin-5-yl)benzamide is used as a research tool in the field of neuroscience and drug development. Its selectivity as a 5-HT6 serotonin receptor antagonist makes it valuable for studying the receptor's role in cognitive and mood-related processes, as well as for developing new therapeutic agents targeting this receptor.
Check Digit Verification of cas no
The CAS Registry Mumber 37481-41-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,7,4,8 and 1 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 37481-41:
(7*3)+(6*7)+(5*4)+(4*8)+(3*1)+(2*4)+(1*1)=127
127 % 10 = 7
So 37481-41-7 is a valid CAS Registry Number.
InChI:InChI=1/C19H22N2O/c1-13-6-4-7-14(2)18(13)19(22)20-17-9-5-8-15-12-21(3)11-10-16(15)17/h4-9H,10-12H2,1-3H3,(H,20,22)
37481-41-7Relevant academic research and scientific papers
Compositions containing 1,2,3,4-tetrahydroisoquinolines used as hypotensive agents
-
, (2008/06/13)
Disclosed are 5,6,7 or 8-nuclear substituted benzamido-1,2,3,4-tetrahydroisoquinolines of the formula STR1 in which R is a phenyl containing one to three hydroxyl, nitro, halo, lower alkyl or lower alkoxy groups, and R1 is hydrogen or a lower alkyl. The compounds lower blood pressure in animals.
